Skip to main content
. 2021 Jan 27;6(1):e01076-20. doi: 10.1128/mSphere.01076-20

TABLE 2.

Antimicrobial resistance phenotype and carriage of antimicrobial resistance genes and chromosomal gene mutations in A. baumannii AC1633 and A. nosocomialis AC1530

Strain Antimicrobial resistance phenotype by class/carriage of resistance genes or chromosomal mutationsb
Carbapenems Cephalosporins Aminoglycosides Tetracyclines Fluoroquinolones Sulfonamides Macrolides
A. baumannii AC1633 IMIR MEMR DORR CTXR FOXR TAZR FEPR GENR AMIS TOBS TETR DOXS CIPR LEVS SXTR ND
    Chromosome blaOXA116 (blaOXA-51-like) blaADC-25 gyrA S81La, parC V104I D105Ea
    pAC1633-1 blaNDM-1, blaOXA-58 aac(3)-IId, aph(3”)-Ib, aph(6)-Id sul2 msrE, mphE
    pAC1633-2 tetA(39)
    pAC1633-3
    pAC1633-4
A. nosocomialis AC1530 IMIR MEMR DORR CTXR FOXR TAZR FEPR GENR AMIS TOBS TETS DOXS CIPS LEVS SXTR ND
    Chromosome blaADC-68 parC V104I D105Ea
    pAC1530 blaNDM-1, blaOXA-58 aac(3)-IId, aph(3”)-Ib, aph(6)-Id sul2 msrE, mphE
a

Mutations in the chromosomally encoded gyrA and parC genes.

b

IMI, imipenem; MEM, meropenem; DOR, doripenem; CTX, ceftriaxone; FOX, cefotaxime; TAZ, ceftazidime; FEP, cefepime; GEN, gentamicin; AMI, amikacin; TOB, tobramycin; TET, tetracycline; DOX, doxycycline; CIP, ciprofloxacin; LEV, levofloxacin; SXT, trimethoprim-sulfamethoxazole; ND, not determined; R, resistance; I, intermediate resistance; S, susceptible.